Profile of molecular mutations in pfdhfr, pfdhps, pfmdr1, and pfcrt genes of Plasmodium falciparum related to resistance to different anti-malarial drugs in the Bata District (Equatorial Guinea)

[1]  Jian Li,et al.  Molecular mutation profile of Pfcrt and Pfmdr1 in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[2]  D. Ishengoma,et al.  High-level Plasmodium falciparum sulfadoxine-pyrimethamine resistance with the concomitant occurrence of septuple haplotype in Tanzania , 2015, Malaria Journal.

[3]  J. Cano,et al.  Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta‐analysis , 2015, Tropical medicine & international health : TM & IH.

[4]  P. Awono-ambene,et al.  Prevalence of Plasmodium falciparum parasites resistant to sulfadoxine/pyrimethamine in pregnant women in Yaoundé, Cameroon: emergence of highly resistant pfdhfr/pfdhps alleles. , 2015, The Journal of antimicrobial chemotherapy.

[5]  F. Kimani,et al.  Chloroquine sensitivity: diminished prevalence of chloroquine-resistant gene marker pfcrt-76 13 years after cessation of chloroquine use in Msambweni, Kenya , 2015, Malaria Journal.

[6]  A. Benito,et al.  Rural-Urban Differences in Household Treatment-Seeking Behaviour for Suspected Malaria in Children at Bata District, Equatorial Guinea , 2015, PloS one.

[7]  D. P. Mawili-Mboumba,et al.  Pfcrt 76T and pfmdr1 86Y allele frequency in Plasmodium falciparum isolates and use of self-medication in a rural area of Gabon. , 2014, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[8]  Jian Li,et al.  High prevalence of pfmdr1 N86Y and Y184F mutations in Plasmodium falciparum isolates from Bioko island, Equatorial Guinea , 2014, Pathogens and global health.

[9]  M. Alifrangis,et al.  Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania , 2014, Malaria Journal.

[10]  Shamilah Hisam,et al.  First case of a naturally acquired human infection with Plasmodium cynomolgi , 2014, Malaria Journal.

[11]  E. Achidi,et al.  Amodiaquine-Artesunate versus Artemether-Lumefantrine against Uncomplicated Malaria in Children Less Than 14 Years in Ngaoundere, North Cameroon: Efficacy, Safety, and Baseline Drug Resistant Mutations in pfcrt, pfmdr1, and pfdhfr Genes , 2013, Malaria research and treatment.

[12]  O. Ndir,et al.  Changes in drug sensitivity and anti-malarial drug resistance mutations over time among Plasmodium falciparum parasites in Senegal , 2013, Malaria Journal.

[13]  C. Roper,et al.  Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria. , 2013, Trends in parasitology.

[14]  J. Karbwang,et al.  Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity , 2013, Malaria Journal.

[15]  P. Awono-ambene,et al.  Molecular monitoring of plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: Implications for the future , 2012, Malaria Journal.

[16]  P. Awono-ambene,et al.  Molecular monitoring of plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: Implications for the future , 2012, Malaria Journal.

[17]  C. Mendes,et al.  Duffy Negative Antigen Is No Longer a Barrier to Plasmodium vivax – Molecular Evidences from the African West Coast (Angola and Equatorial Guinea) , 2011, PLoS neglected tropical diseases.

[18]  M. C. Bolla,et al.  Competitive facilitation of drug-resistant Plasmodium falciparum malaria parasites in pregnant women who receive preventive treatment , 2009, Proceedings of the National Academy of Sciences.

[19]  C. Plowe.  The evolution of drug-resistant malaria. , 2009, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[20]  D. Wirth,et al.  Association between mutations in Plasmodium falciparum chloroquine resistance transporter and P. falciparum multidrug resistance 1 genes and in vivo amodiaquine resistance in P. falciparum malaria-infected children in Nigeria. , 2006, The American journal of tropical medicine and hygiene.

[21]  Nicholas J White,et al.  Antimalarial drug resistance. , 2004, The Journal of clinical investigation.

[22]  R. Snow,et al.  Measurement of trends in childhood malaria mortality in Africa: an assessment of progress toward targets based on verbal autopsy. , 2003, The Lancet. Infectious diseases.

[23]  J. Kublin,et al.  Molecular markers for failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone treatment of Plasmodium falciparum malaria. , 2002, The Journal of infectious diseases.

[24]  B. Lell,et al.  Low-Dose Treatment with Sulfadoxine-Pyrimethamine Combinations Selects for Drug-Resistant Plasmodium falciparum Strains , 1999, Antimicrobial Agents and Chemotherapy.

[25]  J. M. Rubio,et al.  Semi-nested, multiplex polymerase chain reaction for detection of human malaria parasites and evidence of Plasmodium vivax infection in Equatorial Guinea. , 1999, The American journal of tropical medicine and hygiene.

[26]  J. Alvar,et al.  Application and evaluation of QBC malaria diagnosis in a holoendemic area. , 1994, Applied parasitology.